Beauty Health ( NASDAQ:SKIN – Get Rating ) and Cytosorbents ( NASDAQ:CTSO – Get Rating ) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, profitability, risk and valuation. Earnings and Valuation This table compares Beauty Health and Cytosorbents' top-line revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Beauty Health $365.
https://www.dailypolitical.com/2023/04/08/head-to-head-review-beauty-health-nasdaqskin-vs-cytosorbents-nasdaqctso.html#dailypolitical
Du måste logga in före du kommenterar